Cell-Based Therapy for Neural Disorders — Anticipating Challenges

被引:0
|
作者
Arlene Y. Chiu
Mahendra S. Rao
机构
[1] Beckman Research Institute of the City of Hope,
[2] Life Technologies Corporation,undefined
来源
Neurotherapeutics | 2011年 / 8卷
关键词
Pluripotent stem cells; ESC; CNS roadblocks;
D O I
暂无
中图分类号
学科分类号
摘要
Neurological syndromes, such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, Huntington’s disease, amyotrophic lateral sclerosis, and lysosomal storage disorders, such as Battens disease, are devastating because they result in increasing loss of cognitive and physical function. Sadly, no drugs are currently available to halt their progression. The relative paucity of curative approaches for these and other conditions of the nervous system have led to a widespread evaluation of alternative treatment modalities including cell-based interventions. Several cell types have been tested successfully in animal models where safety and efficacy have been demonstrated. Early clinical trials have also been initiated in humans, and some have shown a degree of success albeit on a more limited scale than in animal experiments. Recent demonstrations that pluripotent stem cells, such as embryonic stem cells and induced pluripotent stem cells, can differentiate into a variety of specific neural phenotypes has stimulated worldwide enthusiasm for developing cell-based intervention of neurological disease. Indeed, several groups are preparing investigational new drug applications to treat disorders as diverse as macular degeneration, lysosomal storage diseases, and Parkinson’s disease. It is noteworthy that cell replacement therapies for neurological conditions face key challenges, some of which are unique, because of the development and organization of the nervous system, its metabolism, and connectivity. Choice of the cell (or cells), the process of manufacturing them, defining the delivery pathway, developing and testing in an appropriate preclinical model, selecting a patient population, and visualizing and following or monitoring patients all pose specific issues as related to the central and peripheral nervous systems. In this review, we address a myriad of challenges that are solvable, but require careful planning and attention to the special demands of the human nervous system.
引用
收藏
页码:744 / 752
页数:8
相关论文
共 50 条
  • [41] Cell-based therapy for stroke
    Luo, Yu
    JOURNAL OF NEURAL TRANSMISSION, 2011, 118 (01) : 61 - 74
  • [42] Prospects for cell-based therapy
    Calne, RY
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (10) : 3183 - 3187
  • [43] Cell-based therapy for stroke
    Yu Luo
    Journal of Neural Transmission, 2011, 118 : 61 - 74
  • [44] Somatic Cell-based Therapy
    Hutchinson, James A.
    TRANSPLANTATION, 2015, 99 (06) : 1103 - 1105
  • [45] Cell-Based Therapy for Silicosis
    Lopes-Pacheco, Miqueias
    Bandeira, Elga
    Morales, MarceloM.
    STEM CELLS INTERNATIONAL, 2016, 2016
  • [46] The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy
    Jun Zhang
    Xiaowen Huang
    Haijun Wang
    Xiaoyan Liu
    Tao Zhang
    Yunchuan Wang
    Dahai Hu
    Stem Cell Research & Therapy, 6
  • [47] Mesenchymal Stromal Cell-Based Targeted Therapy Pancreatic Cancer: Progress and Challenges
    Ma, Zhilong
    Hua, Jie
    Liu, Jiang
    Zhang, Bo
    Wang, Wei
    Yu, Xianjun
    Xu, Jin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [48] Stem cell-based ischemic stroke therapy: Novel modifications and clinical challenges
    Sun, Yuankai
    Jiang, Xinchi
    Gao, Jianqing
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 19 (01)
  • [49] The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy
    Zhang, Jun
    Huang, Xiaowen
    Wang, Haijun
    Liu, Xiaoyan
    Zhang, Tao
    Wang, Yunchuan
    Hu, Dahai
    STEM CELL RESEARCH & THERAPY, 2015, 6
  • [50] Stem cell-based ischemic stroke therapy:Novel modifications and clinical challenges
    Yuankai Sun
    Xinchi Jiang
    Jianqing Gao
    Asian Journal of Pharmaceutical Sciences, 2024, 19 (01) : 20 - 36